ES2385683A1 - Compositions for the treatment of pain and/or inflammation. (Machine-translation by Google Translate, not legally binding) - Google Patents

Compositions for the treatment of pain and/or inflammation. (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2385683A1
ES2385683A1 ES201031527A ES201031527A ES2385683A1 ES 2385683 A1 ES2385683 A1 ES 2385683A1 ES 201031527 A ES201031527 A ES 201031527A ES 201031527 A ES201031527 A ES 201031527A ES 2385683 A1 ES2385683 A1 ES 2385683A1
Authority
ES
Spain
Prior art keywords
inflammation
pain
treatment
translation
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201031527A
Other languages
Spanish (es)
Other versions
ES2385683B1 (en
Inventor
Cristina SERRAÏMA CARREÑO
Win Van Den Nest
Antonio Ferrer Montiel
María CAMPRUBÍ ROBLES
Jimena FERNÁNDEZ CARNEADO
Berta Ponsati Obiols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
DiverDrugs SL
BCN Peptides SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DiverDrugs SL, BCN Peptides SA filed Critical DiverDrugs SL
Priority to ES201031527A priority Critical patent/ES2385683B1/en
Publication of ES2385683A1 publication Critical patent/ES2385683A1/en
Application granted granted Critical
Publication of ES2385683B1 publication Critical patent/ES2385683B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

Compositions for the treatment of pain and/or inflammation comprising at least one peptide of general formula (I) r1 -aa-r2, its stereoisomers, mixtures of the same, and their cosmetically and pharmaceutically acceptable salts, where aa is a sequence of 3 to 40 adjacent amino acids contained in the amino acid sequence of the snap-25 protein. Peptide of general formula (I), its stereoisomers, mixtures thereof, and their cosmetically and pharmaceutically acceptable salts for the treatment of pain and/or inflammation. (Machine-translation by Google Translate, not legally binding)
ES201031527A 2010-10-18 2010-10-18 COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION. Active ES2385683B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201031527A ES2385683B1 (en) 2010-10-18 2010-10-18 COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201031527A ES2385683B1 (en) 2010-10-18 2010-10-18 COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION.

Publications (2)

Publication Number Publication Date
ES2385683A1 true ES2385683A1 (en) 2012-07-30
ES2385683B1 ES2385683B1 (en) 2013-10-07

Family

ID=46489529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201031527A Active ES2385683B1 (en) 2010-10-18 2010-10-18 COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION.

Country Status (1)

Country Link
ES (1) ES2385683B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2532749R1 (en) * 2013-09-30 2015-05-06 Universidad Miguel Hernández De Elche BLOCKING PEPTIDES OF THERMORECEPTORS AND THEIR USES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
ES2322882A1 (en) * 2006-10-25 2009-06-30 Lipotec, S.A. Neuronal exocytosis inhibiting peptides
WO2010009892A2 (en) * 2008-07-24 2010-01-28 Bcn Peptides, S.A. Compositions for the treatment of pain and/or inflamation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180524A1 (en) * 1999-04-23 2002-02-20 Lipotec, S.A. Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
ES2322882A1 (en) * 2006-10-25 2009-06-30 Lipotec, S.A. Neuronal exocytosis inhibiting peptides
WO2010009892A2 (en) * 2008-07-24 2010-01-28 Bcn Peptides, S.A. Compositions for the treatment of pain and/or inflamation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2532749R1 (en) * 2013-09-30 2015-05-06 Universidad Miguel Hernández De Elche BLOCKING PEPTIDES OF THERMORECEPTORS AND THEIR USES

Also Published As

Publication number Publication date
ES2385683B1 (en) 2013-10-07

Similar Documents

Publication Publication Date Title
EA201270824A1 (en) COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS
PH12014500922A1 (en) Insulinotropic peptide derivative wherein its n-terminal amino acid is modified
BR112017012474A2 (en) peptide compound, cosmetic or dermopharmaceutical composition, use of at least one peptide compound, and method for increasing activity in the synthesis of skin ecm macromolecules of a peptide compound.
ES2356883A1 (en) Compositions for the treatment of pain and/or inflamation
BR112012029975A2 (en) peptide as a medicine, in particular for the treatment of cancer.
ES2397889A1 (en) Pgc-1alpha-modulating peptides
UA116871C2 (en) METHOD OF TREATMENT OF MYELODYLASPLASTIC SYNDROME, THALASEMIA AND SERIOUS-CELL ANEMIA WITH THE USE OF ACTIVIPURIA ANTAGONISTU ANTAGONIST
EP2528934A4 (en) Aromatic-cationic peptides and uses of same
MX2012010161A (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease.
MX2015005980A (en) Dermal compositions containing unnatural hygroscopic amino acids.
CL2012002560A1 (en) Methods for the treatment of diabetic foot ulcers comprising a peptide of at least 5 contiguous amino acids of nle3 to (1-7) effective; Pharmaceutical formulation comprising hydroxyethyl cellulose (hec) and a peptide of at least 5 contiguous amino acids of nle3 to (1-7).
EA201391387A1 (en) NEUROPROTECTIVE PEPTIDES
NZ594067A (en) VISFATIN THERAPEUTIC AGENTS (PEPTIDES, siRNA, FK-866, APO866 ) FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
EA201590601A1 (en) APPLICATION OF PEDF-DERIVED POLYPEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS
NZ756128A (en) Novel peptides and analogs for use in the treatment of oral mucositis
MX2013002208A (en) Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes.
EA201691328A1 (en) BETA HAIRPILE PEPTIDOMYMETICS AS A SELECTIVE ELASTASY INHIBITORS
NZ705389A (en) Methods of treating hair related conditions
MX2012002154A (en) Regulating the amino acid pool used for the acute-phase protein synthesis.
MX2010001381A (en) Genes and proteins of brachyspira hyodysenteriae and uses thereof.
WO2012153337A3 (en) Anti-microbial peptides and uses of same
MX2011007108A (en) Stroke-generated angiogenesis enhancers and uses thereof.
ES2385683A1 (en) Compositions for the treatment of pain and/or inflammation. (Machine-translation by Google Translate, not legally binding)
BR112012026999A2 (en) casein peptide for use in the treatment of uterine infections.

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905

FG2A Definitive protection

Ref document number: 2385683

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20131007